ITMCTR2000003177尚未招募4 期
A multicenter, randomized, double-blind, very low-dose, parallel controlled trial for the immediate analgesic effect and safety of Kai-Hou- Jian spray (children's type) in the treatment of sore throat caused by acute pharyngitis and tonsillitis in children
The First Teaching Hospital of Tianjin University of TCM0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 4 至 12(—)
- 性别
- All
入选标准
- •1. Clinical diagnosis of acute pharyngitis/acute tonsillitis;
- •2. Wind-heat syndrome or heat exuberance in lung and stomach syndrome in TCM;
- •3. Wong-Baker FACES Pain Rating Scale (WBS) of immediate sore throat >=4 , body temperature <38.5 degrees C;
- •4. Aged 4 to 12 years, can use WBS correctly;
- •5. The informed consent process should be conducted in accordance with the regulations, and the legal guardian or the child (>=8 years old) shall jointly sign the informed consent.
排除标准
- •1. At the first diagnosis, the child's condition is more serious, and he/she suffers from poor mental state, irritability, headache, or limb muscle pain, and needs antipyretic and analgesic drugs;
- •2. Children or their parents/caregivers have difficulty understanding or cooperating with the use of WBS;
- •3. Children with peritonsillar or retropharyngeal abscesses, infectious mononucleosis, and measles and scarlet fever;
- •4. Children with severe primary diseases of heart, lung, liver, kidney, metabolism, hematopoietic, immune, nervous and spiritual systems;
- •5. Children with acute laryngitis, otitis media, bronchitis, pneumonia and other complications;
- •6. Allergic to the experimental drug (KHJS) and its components, and allergic to antipyretic analgesics;
- •7. Those who had taken acetaminophen, ibuprofen or other antipyretic analgesic within 6 hours before enrollment;
- •8. Those who the researchers deemed unsuitable for the study.
研究者
相似试验
进行中(未招募)
1 期
Efficacy and safety of finerenone in subjects with chronic heart failure at high risk of recurrent heart failure decompensatioEUCTR2015-002168-17-CZBayer HealthCare AG5,890
进行中(未招募)
不适用
A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled study to assess the efficacy, safety and tolerability of taspoglutide (RO5073031) compared to sitagliptin and placebo in patients with type 2 diabetesmellitus inadequately controlled with metformin.EUCTR2008-001854-42-GBF.Hoffmann-La Roche Ltd630
进行中(未招募)
不适用
A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled study to assess the efficacy, safety and tolerability of taspoglutide (RO5073031) compared to sitagliptin and placebo in patients with type 2 diabetesmellitus inadequately controlled with metformin.Estudio multicéntrico, randomizado, doble ciego, con doble enmascaramiento, controlado frente a placebo y a un comparador activo para evaluar la eficacia, seguridad y tolerancia de taspoglutida (RO5073031) comparado con sitagliptina y placebo en pacientes con diabetes mellitus tipo 2 controlados inadecuadamente con metformina.Type 2 diabetes mellitusDiabetes Mellitus tipo IIMedDRA version: 9.1Level: LLTClassification code 10012601Term: Diabetes mellitusEUCTR2008-001854-42-ESF.Hoffmann-La Roche Ltd630
进行中(未招募)
1 期
Efficacy and safety of finerenone in subjects with chronic heart failure at high risk of recurrent heart failure decompensatioEUCTR2015-002168-17-PLBayer HealthCare AG5,890
进行中(未招募)
不适用
A multicenter, randomized, double-blind, double-dummy, placebo-controlled, 3-way crossover, single dose study, comparing the efficacy and safety of the Fluticasone/Salmeterol combination administered with Elpenhaler®db (Rolenium®) versus the innovative one (Seretide Diskus®) in patients with asthma.EUCTR2008-000193-21-GRElpen Pharmaceutical Co. Inc.42
